This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Wall Street Bulls Look Optimistic About UnitedHealth (UNH): Should You Buy?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
UnitedHealth Beats on Q4 Earnings, Shares Slip: ETFs in Focus
by Sweta Killa
The largest U.S. health insurer UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2023 results but medical costs rose more than expected for the first time in two years.
UnitedHealth (UNH) Stock Declines 3.4% on High Medical Costs
by Zacks Equity Research
As more seniors resume elective procedures, claims rise in UnitedHealth's (UNH) Medicare Advantage business.
UnitedHealth Group (UNH) Q4 Earnings Beat on Membership Growth
by Zacks Equity Research
UnitedHealth Group's (UNH) Q4 results benefit on the back of double-digit revenue growth in its UnitedHealthcare and Optum segments. Management maintains its 2024 adjusted EPS target within $27.50-$28.00.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge.
PPI Moves Lower, Along with Big Banks on Q4 Earnings
by Mark Vickery
Many of today's PPI metrics clearly point to low-growth elements within the wholesale market.
UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
UnitedHealth Group (UNH) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
UnitedHealth (UNH) delivered earnings and revenue surprises of 3.01% and 2.57%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Q4 Earnings from Wall Street On Deck: JPMorgan, Citi, BofA and Wells Fargo
by Mark Vickery
We turn our attention to Q4 earnings season, which picks up steam Friday morning before the opening bell.
December CPI Hotter-Than-Expected
by Zacks Equity Research
December CPI Hotter-Than-Expected
Can UnitedHealth's (UNH) UnitedHealthcare Unit Aid Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results are expected to benefit from an increase in UnitedHealthcare's Medicare & Retirement revenues as well as the number of people it served.
CPI Warmer than Expected; Jobless Claims Stay Low
by Mark Vickery
Core CPI year over year of +3.9% is the first sub-4% print since May 2021.
Will Q4 Earnings Push Dow ETF Higher?
by Sweta Killa
Let's delve deeper into the probable fourth-quarter earnings picture that will likely aid Dow ETF in the coming days.
Wall Street Awaits Key Inflation Data
by Zacks Equity Research
Wall Street Awaits Key Inflation Data
Quiet Before the Economic Data Storm
by Mark Vickery
Among big news on deck this week are CPI and PPI data, Weekly Jobless Claims and the start of Q4 earnings season.
Can UnitedHealth (UNH) Q4 Earnings Navigate Through High Costs?
by Zacks Equity Research
UnitedHealth's (UNH) fourth-quarter results are likely to reflect growth in domestic commercial customers and premium levels.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
The Zacks Analyst Blog Highlights Apple, UnitedHealth Group, Exxon Mobil, The Boeing and AT&T
by Zacks Equity Research
Apple, UnitedHealth Group, Exxon Mobil, The Boeing and AT&T are part of the Zacks top Analyst Blog.
Top Stock Reports for Apple, UnitedHealth & Exxon Mobil
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), UnitedHealth Group Incorporated (UNH) and Exxon Mobil Corporation (XOM).
Here's Why You Should Hold UnitedHealth Group (UNH) Stock Now
by Zacks Equity Research
Improving membership levels, strategic acquisitions, expanding government business, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth.
Should Invesco S&P 100 Equal Weight ETF (EQWL) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EQWL
UnitedHealth Group (UNH) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $542.03, denoting a +0.5% change from the preceding trading day.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
by Zacks Equity Research
Sector ETF report for RSPH
Should Invesco Dividend Achievers ETF (PFM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for PFM